| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
89,512 |
61,530 |
$2.92M |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
1,820 |
1,781 |
$1.05M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,657 |
17,071 |
$1.03M |
| 59514 |
|
1,074 |
1,058 |
$733K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
8,128 |
7,418 |
$531K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16,810 |
15,753 |
$448K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16,814 |
15,757 |
$447K |
| 81513 |
|
4,628 |
4,334 |
$415K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,575 |
3,429 |
$381K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13,008 |
12,077 |
$334K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,750 |
2,485 |
$227K |
| 87481 |
|
9,721 |
4,808 |
$193K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
7,055 |
6,754 |
$178K |
| 59430 |
|
1,808 |
1,701 |
$142K |
| 87563 |
|
5,151 |
4,747 |
$126K |
| 81002 |
|
36,023 |
23,678 |
$100K |
| 76801 |
|
885 |
749 |
$82K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,918 |
1,895 |
$81K |
| 76830 |
Ultrasound, transvaginal |
786 |
729 |
$71K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,963 |
2,052 |
$65K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
371 |
355 |
$48K |
| 59025 |
Fetal non-stress test |
1,216 |
683 |
$38K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
527 |
387 |
$37K |
| 87625 |
|
1,197 |
1,130 |
$33K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
506 |
466 |
$29K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
500 |
480 |
$28K |
| 81003 |
|
13,471 |
9,137 |
$25K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
671 |
485 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
219 |
210 |
$18K |
| 81025 |
|
2,571 |
2,380 |
$16K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
12 |
12 |
$11K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
220 |
93 |
$10K |
| 87511 |
|
685 |
486 |
$10K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
163 |
156 |
$8K |
| 99205 |
Prolong outpt/office vis |
84 |
81 |
$8K |
| 54160 |
|
42 |
41 |
$7K |
| 99000 |
|
506 |
431 |
$5K |
| 76813 |
|
58 |
50 |
$4K |
| 90715 |
|
112 |
107 |
$3K |
| 81514 |
|
13 |
12 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
288 |
268 |
$3K |
| 99215 |
Prolong outpt/office vis |
39 |
31 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
427 |
363 |
$2K |
| 99385 |
|
27 |
24 |
$2K |
| 58300 |
|
12 |
12 |
$1K |
| 76818 |
|
17 |
12 |
$888.72 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
49 |
39 |
$720.76 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
12 |
12 |
$679.62 |
| 90688 |
|
39 |
39 |
$668.60 |
| 87660 |
|
44 |
38 |
$612.52 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
17 |
14 |
$604.00 |
| 87800 |
|
17 |
14 |
$496.07 |
| 90686 |
|
23 |
22 |
$383.85 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43 |
37 |
$362.32 |
| 84481 |
|
20 |
16 |
$226.56 |
| 84443 |
Thyroid stimulating hormone (TSH) |
20 |
16 |
$225.10 |
| 90658 |
|
13 |
13 |
$207.79 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
15 |
$207.76 |
| 90656 |
|
18 |
16 |
$201.97 |
| 84439 |
|
20 |
16 |
$112.58 |
| 85018 |
|
58 |
53 |
$110.63 |
| 82950 |
|
29 |
28 |
$90.89 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
93 |
88 |
$66.23 |
| 87210 |
|
14 |
13 |
$65.76 |
| 99001 |
|
14 |
13 |
$60.10 |
| 80305 |
|
88 |
65 |
$53.96 |
| 99459 |
|
106 |
99 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
58 |
45 |
$0.00 |
| 96127 |
|
39 |
33 |
$0.00 |